IMPACT OF TUMOR EMBRYOLOGIC ORIGIN ON THE EFFICACY OF FIRST-LINE CHEMOTHERAPY IN METASTATIC COLORECTAL CANCER (mCRC) PATIENTS: A PILOT RETROSPECTIVE STUDY

被引：0
|
作者：
Valenti, Vicente [1 ]
Ramos, Javier [1 ]
Marcos, Pilar [2 ]
Perez, Cristina [1 ]
Esteller, Laura [1 ]
Sales, Ricard [1 ]
Montserrat, Angels [1 ]
Rossini, Alejandro [1 ]
Alvarez, Ana [2 ]
Germa, Josep [2 ]
机构：
[1] Xarxa Hosp Santa Tecla, Tarragona El Vendrell, Spain
[2] Capio Hosp Gen Catalunya, Sant Cugat Del Valles, Spain
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：v99 / v99
页数：1
相关论文
共 50 条
  • [41] EFFICACY AND SAFETY OF CETUXIMAB, OXALIPLATIN AND CAPECITABINE AS FIRST-LINE THERAPY FOR METASTATIC COLORECTAL CANCER (MCRC): RESULTS OF A PHASE II STUDY
    Barroso, S.
    Sanches, E.
    Ferreira, J.
    Passos, M.
    Sa, A.
    Nabico, R.
    SottoMayor, C.
    Santo, Espirito J.
    San-Bento, R.
    ANNALS OF ONCOLOGY, 2009, 20 : 65 - 65
  • [42] Efficacy and safety of cetuximab, oxaliplatin, and capecitabine as first-line therapy for metastatic colorectal cancer (mCRC): Results of a phase II study
    Barroso, S. A.
    Sanches, E.
    Ferreira, M.
    Passos, M.
    Sa, A.
    Nabico, R.
    Sotto-Mayor, C.
    Santo, J. Espirito
    San-Bento, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [43] EFFICACY OF BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY WITH IRINOTECAN AND CAPECITABINE (XELIRI) IN FIRST-LINE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
    Ocvirk, J.
    Rebersek, M.
    Boc, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 129 - 129
  • [44] Efficacy and safety of first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a meta-analysis
    Wang Ming
    Zheng Xiaofeng
    Ruan Xiaojiao
    Ye Bailiang
    Cai Long
    Lin Feizhuan
    Tu Jinfu
    Jiang Feizhao
    Li Shaotang
    CHINESE MEDICAL JOURNAL, 2014, 127 (03) : 538 - 546
  • [45] Circannual variation of efficacy outcomes in patients with newly diagnosed metastatic colorectal cancer and treated with first-line chemotherapy
    Tampellini, M.
    Polverari, R. S.
    Ottone, A.
    Alabiso, I.
    Baratelli, C.
    Bitossi, R.
    Brizzi, M. P.
    Leone, F.
    Forti, L.
    Bertona, E.
    Racca, P.
    Mecca, C.
    Alabiso, O.
    Aglietta, M.
    Berruti, A.
    Scagliotti, G. V.
    CHRONOBIOLOGY INTERNATIONAL, 2015, 32 (10) : 1359 - 1366
  • [46] Capecitabine plus irinotecan (CAPIRI) as first-line treatment for patients (Pts) with metastatic colorectal cancer (MCRC)
    Laudani, A.
    Savio, G.
    Leonardi, V.
    Palmisano, V.
    Tartaglia, L.
    Manuguerra, G.
    Pepe, A.
    Alu, M.
    Usset, A.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2007, 18 : 6 - 6
  • [47] EFFECTIVENESS AND SAFETY OF FIRST-LINE BEVACIZUMAB PLUS FOLFIRI IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC)
    Pinto, Ana Catarina
    Teixeira, Margarida
    Bonito, Nuno
    Jacinto, Paula
    Ribeiro, Joao
    Gervasio, Helena
    ANNALS OF ONCOLOGY, 2011, 22 : v98 - v98
  • [48] PRELIMINARY EFFICACY OF BEVACIZUMAB WITH FIRST LINE CHEMOTHERAPY BY FOLFOX OR FOLFIRI FOR METASTATIC COLORECTAL CANCER (MCRC): AN ALGERIAN EXPERIENCE
    Bensalem, A.
    Bouzid, K.
    ANNALS OF ONCOLOGY, 2009, 20 : 40 - 40
  • [49] Italian observational study in patients with metastatic colorectal cancer (mCRC) treated with first-line cetaximab based regimen (ObservEr study)
    Di Fabio, Francesca
    Rosati, Gerardo
    Lolli, Ivan Roberto
    Ruggeri, Enzo Maria
    Cluffreda, Libero
    Ferrari, Daris
    Tumolo, Salvatore
    Rostl, Giovanni
    Tralongo, Paolo
    Ferrara, Raimondo
    Alabiso, Oscar
    Chiara, Silvana
    Ianniello, Giovanni Paolo
    Di Costanzo, Francesco
    Frassoldati, Antonio
    Iacono, Carmelo
    Clerico, Mario
    Pavesl, Lorenzo
    Bernardo, Giovanni
    Pinto, Carmine
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] Capecitabine plus irinotecan (CAPIRI) as first-line treatment for patients (PTS) with metastatic colorectal cancer (MCRC)
    Laudani, Agata
    Savio, Giuseppina
    Leonardi, Vita
    Palmisano, Valentina
    Rondello, Giacomo
    Alu, Massimiliano
    Pepe, Alessio
    Calabria, Caterina
    Usset, Antonella
    Agostara, Biagio
    ANNALS OF ONCOLOGY, 2006, 17 : 119 - 119
12345